Suppr超能文献

质子泵抑制剂治疗无效的胃食管反流症状:GERD、NERD、NARD、食管高敏还是消化不良?

Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

出版信息

Can J Gastroenterol Hepatol. 2014 Jun;28(6):335-41. doi: 10.1155/2014/904707. Epub 2014 Apr 9.

Abstract

Gastroesophageal reflux (GER) is a common gastrointestinal process that can generate symptoms of heartburn and chest pain. Proton pump inhibitors (PPIs) are the gold standard for the treatment of GER; however, a substantial group of GER patients fail to respond to PPIs. In the past, it was believed that acid reflux into the esophagus causes all, or at least the majority, of symptoms attributed to GER, with both erosive esophagitis and nonerosive outcomes. However, with modern testing techniques it has been shown that, in addition to acid reflux, the reflux of nonacid gastric and duodenal contents into the esophagus may also induce GER symptoms. It remains unknown how weakly acidic or alkaline refluxate with a pH similar to a normal diet induces GER symptoms. Esophageal hypersensitivity or functional dyspepsia with superimposed heartburn may be other mechanisms of symptom generation, often completely unrelated to GER. Detailed studies investigating the pathophysiology of esophageal hypersensitivity are not conclusive, and definitions of the various disease states may overlap and are often confusing. The authors aim to clarify the pathophysiology, definition, diagnostic techniques and medical treatment of patients with heartburn symptoms who fail PPI therapy.

摘要

胃食管反流(GER)是一种常见的胃肠道过程,可产生烧心和胸痛等症状。质子泵抑制剂(PPIs)是 GER 治疗的金标准;然而,相当一部分 GER 患者对 PPI 治疗无反应。过去,人们认为胃酸反流到食管会引起 GER 所有或至少大部分归因于 GER 的症状,包括糜烂性食管炎和非糜烂性结果。然而,随着现代检测技术的发展,已经表明除了胃酸反流之外,非酸性胃和十二指肠内容物的反流也可能引起 GER 症状。目前尚不清楚具有与正常饮食相似 pH 值的弱酸性或碱性反流物如何引起 GER 症状。食管高敏或伴有烧心的功能性消化不良可能是其他症状产生的机制,通常与 GER 完全无关。对食管高敏的病理生理学进行的详细研究尚无定论,并且各种疾病状态的定义可能重叠且经常令人困惑。作者旨在阐明对 PPI 治疗失败的烧心症状患者的病理生理学、定义、诊断技术和医学治疗。

相似文献

1
Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?
Can J Gastroenterol Hepatol. 2014 Jun;28(6):335-41. doi: 10.1155/2014/904707. Epub 2014 Apr 9.
2
Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Dis Esophagus. 2013 Jul;26(5):443-50. doi: 10.1111/j.1442-2050.2012.01381.x. Epub 2012 Aug 2.
5
How to differentiate non-erosive reflux disease from functional heartburn.
J Dig Dis. 2012 Dec;13(12):605-8. doi: 10.1111/j.1751-2980.2012.00637.x.
6
[Underlying Mechanisms and Management of Refractory Gastroesophageal Reflux Disease].
Korean J Gastroenterol. 2015 Aug;66(2):70-4. doi: 10.4166/kjg.2015.66.2.70.
7
Untangling Nonerosive Reflux Disease From Functional Heartburn.
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1314-1326. doi: 10.1016/j.cgh.2020.03.057. Epub 2020 Apr 1.
8
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
Neurogastroenterol Motil. 2014 Jan;26(1):28-35. doi: 10.1111/nmo.12221. Epub 2013 Aug 29.
9
The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children.
J Pediatr. 2017 Oct;189:86-91. doi: 10.1016/j.jpeds.2017.06.019. Epub 2017 Jul 12.
10
Between GERD and NERD: the relevance of weakly acidic reflux.
Ann N Y Acad Sci. 2016 Sep;1380(1):218-229. doi: 10.1111/nyas.13169. Epub 2016 Jul 29.

引用本文的文献

本文引用的文献

1
Proton pump inhibitor therapy and potential long-term harm.
Curr Opin Endocrinol Diabetes Obes. 2014 Feb;21(1):3-8. doi: 10.1097/MED.0000000000000031.
3
Management of the patient with incomplete response to PPI therapy.
Best Pract Res Clin Gastroenterol. 2013 Jun;27(3):401-14. doi: 10.1016/j.bpg.2013.06.005.
4
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review.
Gut. 2014 Jun;63(6):871-80. doi: 10.1136/gutjnl-2012-304269. Epub 2013 Jul 13.
5
Do endoscopic antireflux procedures fit in the current treatment paradigm of gastroesophageal reflux disease?
Clin Gastroenterol Hepatol. 2014 Apr;12(4):544-54. doi: 10.1016/j.cgh.2013.06.012. Epub 2013 Jun 28.
6
ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).
Am J Gastroenterol. 2013 May;108(5):679-92; quiz 693. doi: 10.1038/ajg.2013.71. Epub 2013 Apr 9.
7
Role of nociceptors/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease.
Dig Dis Sci. 2013 Aug;58(8):2237-43. doi: 10.1007/s10620-012-2337-7. Epub 2012 Aug 17.
9
Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Dis Esophagus. 2013 Jul;26(5):443-50. doi: 10.1111/j.1442-2050.2012.01381.x. Epub 2012 Aug 2.
10
Systematic review: hypomagnesaemia induced by proton pump inhibition.
Aliment Pharmacol Ther. 2012 Sep;36(5):405-13. doi: 10.1111/j.1365-2036.2012.05201.x. Epub 2012 Jul 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验